Abstract
RNA-binding proteins (RBPs) play a critical role in the regulation of various RNA processes, including splicing, cleavage and polyadenylation, transport, translation and degradation of coding RNAs, non-coding RNAs and microRNAs. Recent studies indicate that RBPs not only play an instrumental role in normal cellular processes but have also emerged as major players in the development and spread of cancer. Herein, we review the current knowledge about RNA binding proteins and their role in tumorigenesis as well as the potential to target RBPs for cancer therapeutics.
Original language | English (US) |
---|---|
Article number | 107390 |
Journal | Pharmacology and Therapeutics |
Volume | 203 |
DOIs | |
State | Published - Nov 2019 |
Keywords
- Aptamer
- Cancer therapeutics
- Peptide
- RNA-binding domains
- RNA-binding proteins
- siRNA
- Small molecules
ASJC Scopus subject areas
- Pharmacology
- Pharmacology (medical)